A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma

Summary

The purpose of this study is to evaluate the pharmacokinetic (PK-the study of the way a drug enters and leaves the blood and tissues over time) characteristics of bortezomib when administered intravenously in Taiwanese participants with multiple myeloma (cancer of the types of cells normally found in bone marrow).

Timeline

Start

2014-12

Primary completion

2015-07

Completion

2015-07

Drugs

Indications